Coronary endothelial dysfunction and impaired microcirculation response to atrial natriuretic peptide in
Takashi Ashikaga1, Mitsuhiro Nishizaki, Hiroyuki Fujii
1Department of Cardiology, Yokohama Minami Kyosai Hospital, 1-21-1 Mutsuurahigashi, Kanazawa-ku, Yokohama City, Kanagawa 236-0037, Japan. ashikaga-ind@umin.ac.jp
Insights
Hyperinsulinemia (HI) is linked to endothelial dysfunction. In patients with HI, atrial natriuretic peptide response in coronary microcirculation is significantly blunted, suggesting a pathological effect even in mild cases.
Area of Science:
- Cardiology
- Endocrinology
- Vascular Biology
Background:
- Endothelial dysfunction is a known complication of hyperinsulinemia (HI).
- Assessing coronary microcirculation responses to vasoactive agents is crucial for understanding vascular health in patients with normal coronary arteries.
Purpose of the Study:
- To investigate coronary microcirculation responses to various vasoactive agents in patients with normoinsulinemia (NI) versus hyperinsulinemia (HI).
- To evaluate the impact of HI on endothelial function and microvascular reactivity.
Main Methods:
- 57 patients with angiographically normal coronary arteries were divided into NI (n=37) and HI (n=20) groups based on an oral glucose tolerance test.
- Epicardial artery vasoactivity was assessed using acetylcholine chloride.
- Coronary microcirculation function was evaluated via intracoronary administration of adenosine triphosphate, isosorbide dinitrate, and atrial natriuretic peptide.
Main Results:
- Epicardial artery vasoconstriction to acetylcholine was mildly reduced in the HI group (P = .04).
- Coronary flow reserve to adenosine triphosphate was similar between NI and HI groups.
- In the HI group, the response of peak velocity to atrial natriuretic peptide was significantly blunted compared to isosorbide dinitrate (P < .001), unlike in the NI group.
Conclusions:
- Hyperinsulinemia is associated with mild endothelial dysfunction affecting epicardial arteries.
- Atrial natriuretic peptide response is significantly impaired in the coronary microcirculation of patients with HI, even with mild endothelial dysfunction.
- These findings suggest a potential pathological role for atrial natriuretic peptide in HI-related microvascular impairment.
Abstract:
Endothelial dysfunction occurs in hyperinsulinemia (HI). Coronary microcirculation responses to vasoactive agents are examined in 57 patients with angiographically normal coronary arteries. Patients were divided into 2 groups, 37 with normoinsulinemia (NI) and 20 with HI based on results of a 75-g oral glucose tolerance test. Epicardial artery vasoactivity in response to acetylcholine chloride is measured to assess endothelial function. Coronary microcirculation function is evaluated by intracoronary administration of 50 microg of adenosine triphosphate, 1 mg of isosorbide dinitrate, and 0.05 mg/kg of atrial natriuretic peptide. Epicardial artery vasoconstriction in response to 100 microg of acetylcholine is mildly reduced in HI (P = .04). Coronary flow reserve in response to adenosine triphosphate in NI is similar to that in HI. In NI, the resting mean (SD) peak velocity in response to isosorbide dinitrate (40.7 [10.9] cm/s) vs atrial natriuretic peptide (39.6 [10.9] cm/s) is similar. In contrast, the resting mean (SD) peak velocity in response to atrial natriuretic peptide (31.3 [9.3] cm/s) vs isosorbide dinitrate (43.5 [10.0] cm/s) in HI is statistically significantly blunted (P < .001). Atrial natriuretic peptide may have a pathologic effect on coronary microcirculation even in mild endothelial dysfunction among patients with HI.
Related Concept Videos
Diabetic Nephropathy
Heart Failure II: Pathophysiology
Coronary Artery Disease I: Introduction
Type II Diabetes II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology
